Stay updated on Pembrolizumab for Pediatric Hodgkin Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab for Pediatric Hodgkin Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab for Pediatric Hodgkin Lymphoma Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2 and removed Revision: v3.4.1.
    Difference
    0.0%
    Check dated 2026-02-13T12:51:53.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    Minor update: the page now displays Revision: v3.4.1 and removes Revision: v3.4.0, indicating a small version bump. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-06T09:14:24.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    Added show/hide glossary controls and updated footer labels (including capitalization changes for QC criteria and FEAR Act data) with Revision: v3.4.0.
    Difference
    0.2%
    Check dated 2026-01-22T18:00:02.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    Revision update: added v3.3.4 and removed v3.3.3. This appears to be an internal version-control change with no user-facing content changes.
    Difference
    0.0%
    Check dated 2026-01-14T03:37:15.000Z thumbnail image
  6. Check
    57 days ago
    Change Detected
    Summary
    Locations section updated with a major reorganization: numerous site entries were added across the US, Europe, Africa, South America, and Asia, while other entries were removed. The study site list now reflects the current recruiting locations and may affect where participants can enroll.
    Difference
    3%
    Check dated 2025-12-23T20:30:57.000Z thumbnail image
  7. Check
    85 days ago
    Change Detected
    Summary
    The Publications section description was reworded and the revision tag updated from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-25T10:30:46.000Z thumbnail image

Stay in the know with updates to Pembrolizumab for Pediatric Hodgkin Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Pediatric Hodgkin Lymphoma Clinical Trial page.